Cargando…
PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression
BACKGROUND: Protection of islets without systemic immunosuppression has been a long-sought goal in the islet transplant field. We conducted a pilot biocompatibility/safety study in healthy dogs followed by a dose-finding efficacy study in diabetic dogs using polyethylene glycol diacrylate (PEGDA) mi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132281/ https://www.ncbi.nlm.nih.gov/pubmed/35613086 http://dx.doi.org/10.1371/journal.pone.0267814 |